Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC

The study was performed to investigate the antitumor efficacy of histone deacetylase inhibitor (HDACi) chidamide alone or with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) icotinib in non-small cell lung cancer (NSCLC). The cell viability, cell cycle, apoptosis, protein expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ningning, Liang, Caixia, Song, Wenya, Tao, Dan, Yao, Jiarui, Wang, Shuai, Ma, Li, Shi, Yuankai, Han, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400687/
https://www.ncbi.nlm.nih.gov/pubmed/30854137
http://dx.doi.org/10.7150/jca.28570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400687/
https://www.ncbi.nlm.nih.gov/pubmed/30854137
http://dx.doi.org/10.7150/jca.28570

Ejemplares similares